peptide amyloide beta amyloid β peptide (Aβ - Aβ42 amyloid β peptide (Aβ

Lecanemab

Peptide Amyloide Beta: Understanding Its Role in Alzheimer's Disease

Peptide amyloide beta (Aβ) is a critical molecule deeply implicated in the neurodegenerative processes of Alzheimer's disease (AD). These peptides, typically 36 to 43 amino acids long, are fragments derived from the amyloid precursor protein (APP) and are known to be the primary component of amyloid plaques found in the brains of individuals with AD. The accumulation and aggregation of Aβ peptides are widely believed to initiate and drive the progression of this debilitating disease, leading to synaptic damage, neuronal loss, and cognitive declineAlzheimer : des anticorps contre la β-amyloïde.

The formation of amyloid beta peptides is a complex biological process. They are generated through the enzymatic cleavage of the larger amyloid precursor protein (APP), a transmembrane protein expressed in various tissues, particularly concentrated in neuronal synapses. This cleavage is carried out by enzymes known as secretases, specifically β-secretase (BACE1) and γ-secretaseBeta-Amyloid (1-42). While the production of Aβ peptides is a normal cellular event, an imbalance in their production, clearance, or aggregation can lead to their pathological accumulation.

#### The Pathological Cascade of Amyloid Beta

The aggregation of amyloid beta peptides is a hallmark of Alzheimer's disease作者：Y Xu·2005·被引用次数：331—The amyloid β-peptides (Aβs), containing 39–43 residues, are thekey protein components of amyloid deposits in Alzheimer's disease.. These peptides can misfold and clump together, forming soluble oligomers, protofibrils, and eventually insoluble amyloid plaques. While plaques themselves are a characteristic feature, emerging research suggests that smaller, soluble oligomeric forms of Aβ may be more neurotoxic. These oligomers can disrupt synaptic function, interfere with neuronal signaling, and trigger inflammatory responses within the brain.作者：G Chen·2017·被引用次数：2725—Amyloid beta peptide (Aβ)is produced through the proteolytic processing of a transmembrane protein, amyloid precursor protein (APP), by β- and γ-secretases.

Different isoforms of the amyloid beta peptide exist, with Aβ(1-40) and Aβ(1-42) being the most prominent. Aβ(1-42) is particularly noteworthy as it is considered the principal species associated with the formation of senile plaques, a defining pathological feature of AD. Conversely, Aβ(1-40) is more abundant in cerebrovascular amyloid deposits. The ratio of these isoforms and their propensity to aggregate play a significant role in disease pathogenesis作者：MO Quartey·2021·被引用次数：58—Aβ(1–38) reverses the negative impact of Aβ(1–42) on long-term potentiation in acute hippocampal slices and on membrane conductance in primary neurons..

#### Therapeutic Strategies Targeting Amyloid Beta

Given the central role of amyloid beta in Alzheimer's disease, it has become a primary target for therapeutic interventionsβ-Amyloid Peptide (1-42), Human. Researchers are exploring various strategies to reduce the burden of Aβ in the brain or to prevent its aggregation and toxicity. These approaches include:

* Immunotherapy: This involves using monoclonal antibodies (mAbs) or designing synthetic peptides that target Aβ.1IYT: Solution structure of the Alzheimer's disease amyloid ... Antibodies like Lecanemab aim to clear Aβ plaques from the brain, thereby slowing disease progression.

* Inhibitory Peptides: Strategies are being developed to create Aβ-targeted inhibitory peptides that can bind to and prevent the aggregation of these harmful proteins.Aβ, amyloid β peptide, is defined asa peptide of approximately 40 amino acidsthat constitutes the main component of amyloid plaques in the brains of ...

* Modulating Secretase Activity: Pharmaceutical interventions are being investigated to inhibit the activity of BACE1 and γ-secretase, thereby reducing the production of amyloid beta peptides.

* Enhancing Clearance Mechanisms: Research is also focused on understanding and enhancing the brain's natural mechanisms for clearing amyloid beta, such as microglial phagocytosis.

#### Amyloid Beta and Oxidative Stress

Beyond its direct aggregation, amyloid beta peptide toxicity has also been linked to oxidative stress within the brainAmyloid β-based therapy for Alzheimer's disease. The accumulation of Aβ can promote the generation of free radicals, which can lead to lipid peroxidation and protein oxidation. This oxidative damage can further compromise neuronal function and contribute to the neurodegenerative process characteristic of Alzheimer's disease.

In conclusion, peptide amyloide beta is a complex and crucial molecule in the study of Alzheimer's disease.Amyloid Beta Peptide - StatPearls - NCBI Bookshelf Understanding its production, aggregation, various isoforms, and its interaction with cellular processes like oxidative stress is fundamental to developing effective diagnostic tools and therapeutic interventions for this widespread neurodegenerative condition作者：J Delrieu·2014·被引用次数：44—Amyloidβ peptiderepresents an important molecular target for intervention in Alzheimer's disease. The main purpose of this work is to review immunotherapy .... The ongoing research into amyloid beta-targeted therapies offers hope for managing and potentially treating Alzheimer's disease in the future.